Kim CM - Search Results

1

In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.

Hong SH, Jeong JS, Lee YJ, Jung HI, Cho KS, Kim CM, Kwon BS, Sullenger BA, Lee SW, Kim IH. Hong SH, et al. Among authors: kim ih, kim cm. Mol Ther. 2008 Jan;16(1):74-80. doi: 10.1038/sj.mt.6300282. Epub 2007 Aug 14. Mol Ther. 2008. PMID: 17700543 Free article.

2

Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.

Jeong JS, Lee SW, Hong SH, Lee YJ, Jung HI, Cho KS, Seo HH, Lee SJ, Park S, Song MS, Kim CM, Kim IH. Jeong JS, et al. Among authors: kim ih, kim cm. Clin Cancer Res. 2008 Jan 1;14(1):281-90. doi: 10.1158/1078-0432.CCR-07-1524. Clin Cancer Res. 2008. PMID: 18172280

3

Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.

Kong SY, Park JW, Kim JO, Lee NO, Lee JA, Park KW, Hong EK, Kim CM. Kong SY, et al. Among authors: kim jo, kim cm. J Cancer Res Clin Oncol. 2009 Aug;135(8):1091-8. doi: 10.1007/s00432-009-0549-9. Epub 2009 Jan 31. J Cancer Res Clin Oncol. 2009. PMID: 19184104

4

Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation.

Baek KH, Park HY, Kang CM, Kim SJ, Jeong SJ, Hong EK, Park JW, Sung YC, Suzuki T, Kim CM, Lee CW. Baek KH, et al. Among authors: kim sj, kim cm. J Mol Biol. 2006 May 26;359(1):22-34. doi: 10.1016/j.jmb.2006.03.020. Epub 2006 Mar 29. J Mol Biol. 2006. PMID: 16616934

5

Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis.

Jeong SJ, Shin HJ, Kim SJ, Ha GH, Cho BI, Baek KH, Kim CM, Lee CW. Jeong SJ, et al. Among authors: kim sj, kim cm. Cancer Res. 2004 Dec 1;64(23):8666-73. doi: 10.1158/0008-5472.CAN-03-3455. Cancer Res. 2004. PMID: 15574775

6

Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines.

Ryu SY, Kim K, Lee WS, Kwon HC, Lee KH, Kim CM, Kang SB. Ryu SY, et al. Among authors: kim cm, kim k. J Gynecol Oncol. 2009 Mar;20(1):48-54. doi: 10.3802/jgo.2009.20.1.48. Epub 2009 Mar 31. J Gynecol Oncol. 2009. PMID: 19471670 Free PMC article.

7

Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.

Park JW, Park KW, Cho SH, Park HS, Lee WJ, Lee DH, Kim CM. Park JW, et al. Among authors: kim cm. Am J Gastroenterol. 2005 Oct;100(10):2194-200. doi: 10.1111/j.1572-0241.2005.00232.x. Am J Gastroenterol. 2005. PMID: 16181368 Clinical Trial.

8

Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.

Park JW, Park JE, Lee JA, Lee CW, Kim CM. Park JW, et al. Among authors: kim cm. J Cancer Res Clin Oncol. 2006 Mar;132(3):184-92. doi: 10.1007/s00432-005-0060-x. Epub 2005 Dec 6. J Cancer Res Clin Oncol. 2006. PMID: 16331492

9

Caspases-dependent cleavage of mitotic checkpoint proteins in response to microtubule inhibitor.

Baek KH, Shin HJ, Jeong SJ, Park JW, McKeon F, Lee CW, Kim CM. Baek KH, et al. Among authors: kim cm. Oncol Res. 2005;15(3):161-8. doi: 10.3727/096504005776367906. Oncol Res. 2005. PMID: 16050137

10

Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients.

Kong SY, Park JW, Lee JA, Park JE, Park KW, Hong EK, Kim CM. Kong SY, et al. Among authors: kim cm. Hepatology. 2007 Aug;46(2):446-55. doi: 10.1002/hep.21720. Hepatology. 2007. PMID: 17659575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

779 results

Search Page

Filters